Healthcare Smart Beds Market Size to Reach USD 1,166 Million by 2030 Fueled By Growing Improvements in Patient Care Says Acumen Research and Consulting

2022-07-30 01:01:43 By : Ms. Coco Liu

Acumen Research and Consulting recently published report titled “Healthcare Smart Beds Market Size, Share, Analysis Report and Region Forecast, 2022 - 2030”

LOS ANGELES, July 21, 2022 (GLOBE NEWSWIRE) -- The Global Healthcare Smart Beds Market size accounted for USD 561 Million in 2021 and is estimated to reach USD 1,166 Million by 2030.

The increasing importance of patient safety and the integration of advanced technologies in the healthcare sector are the two prominent trends according to healthcare smart beds industry analysis. On top of that, the increasing acceptance of smart beds is another prominent aspect that is expanding the healthcare smart beds market revenue.

Healthcare smart beds are designed to help patients move more easily and quickly regain their normal movement, as this plays a significant role in restoring the patient's wellness, health, and activity. According to studies that confirm that the patient's movement during their stay in the acute medical rooms enhances the speedy recovery and early discharge from the hospital, the bed is the primary tool for this purpose. Additionally, the presence of smart beds benefits healthcare providers because it relieves them of the hassle of changing the patient's position from period to period, which helps them reduce injuries because the smart bed technology keeps the patient in the finest positions while moving the bed. One of the advantages of smart beds is the automatic connection of medical devices with the electronic health records of the patient and with vital signs devices, i.e. the patient’s vital functions, weight measurement devices, respirators, and medicine pumping devices, so that the signs are recorded automatically in the system without the intervention of the nursing staff.

Request For Free Sample Report @

https://www.acumenresearchandconsulting.com/request-sample/3032

By Product Type, By Application, And By Geography

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Arjo, Favero Health Projects SpA, Hill-Rom Holdings, Inc., Invacare Corporation, Joerns Healthcare LLC, LINET, Paramount Bed Holdings Co., Ltd., Stiegelmeyer GmbH & Co. KG, Stryker Corporation, and Völker GmbH.

Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

10 hrs of free customization and expert consultation

COVID-19 Impact on Global Healthcare Smart Beds Market Share

COVID-19 has had an unprecedented and staggering global impact, with smart bed products having a positive impact among all regions during the pandemic. The sudden increase in these beds was recorded due to the increasing number of covid patients getting admitted in hospitals. As per the CDC, COVID-19 increased in-patient bed requirement from 4,16,064 to 5,43,132 in between April and July 2020. As a result, there was an unending need for hospital beds all over the world in 2020 and 2021. However, due to the numerous advantages offered by these beds, the upward trend is expected to continue for the foreseeable future.

Healthcare Smart Beds Market Dynamics

The growing admission of patients in hospitals due to the increase in chronic disorders fuels the healthcare smart beds market share. As per the World Cancer Research Fund, a projected 19.3 million new cancer cases were diagnosed globally in 2020, indicating an increase in global incidences. And, because every chronic disorder necessitates advanced medical treatment, continuous health monitoring, and a longer period of treatment, the demand for these beds is rapidly increasing. Similarly, the high frequency of accidents, paralysis, burn injuries, and other bedridden illnesses are other substantial factors that are expected to drive demand for these beds over the forecast period.

Moreover, the increased demand for technologically advanced gadgets that provide vital health data is expected to bolster the user acceptance of healthcare smart beds in the coming years. Smart beds have improved features and are more innovative in order to offer pleasant changes during connectivity and sleep. As a result, advances in healthcare smart beds are presenting appealing opportunities for market vendors, and the rise of smart hospital beds is expected to accelerate in the coming years.

Check the detailed table of contents of the report @

https://www.acumenresearchandconsulting.com/table-of-content/healthcare-smart-beds-market

Worldwide Healthcare Smart Beds Market Segmentation

The global healthcare smart beds market has been segmented into product type, application, and region. The product type segment covers semi-automatic and fully automatic. Among them, the fully automatic beds are expected to quickly surge the healthcare smart beds market value. The increasing utilization of electric and semi-electric beds, which may provide a variety of benefits such as posture adjustment, the provision of monitoring sensors, and fall alert features, among others, is driving growth in this market.

Hospitals, medical nursing homes, outpatient clinics, and medical laboratories and research are covered under the application segment. In 2021, hospitals held for the maximum healthcare smart beds market share. This is due to an increase in in-patient admissions for chronic illnesses such as cancer, heart disease, and kidney failure. However, the outpatient clinics segment is anticipated to witness the fastest growth rate throughout the projected years.

Healthcare Smart Beds Market Regional Overview

The global healthcare smart beds market regional outlook is given as North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa. In 2021, North America gathered a significant amount of share all over the world. Surging prevalence of chronic disorders, an increasing geriatric population susceptible to age-related disorders, and high per capita healthcare spending in the region are key factors expected to drive the market in North America throughout the forecast period. On the other hand, the European region is likely to witness the highest CAGR in the coming years.

Buy this premium research report –

https://www.acumenresearchandconsulting.com/buy-now/0/3032

Healthcare Smart Beds Market Players

Some healthcare smart beds companies covered globally include Arjo, Invacare Corporation, Favero Health Projects SpA, Hill-Rom Holdings, Inc., Joerns Healthcare LLC, LINET, Paramount Bed Holdings Co., Ltd., Stiegelmeyer GmbH & Co. KG, Stryker Corporation, and Völker GmbH.

Browse More Research Topic on Healthcare Sector:

The Global Healthcare Fabrics Market size accounted for USD 18,598 Million in 2021 and is expected to reach USD 33,606 Million by 2030 with a considerable CAGR of 7% during the forecast timeframe of 2022 to 2030.

The Global Healthcare Informatics Market size accounted for USD 34,774 Million in 2021 and is estimated to reach USD 98,679 Million by 2030, with a significant CAGR of 12.4% from 2022 to 2030.

The Global Healthcare Logistics Market accounted for USD 77.9 Billion in 2021 and is expected to reach USD 158.5 Billion by 2030 with a considerable CAGR of 8.3% during the forecast timeframe of 2022 to 2030.

About Acumen Research and Consulting:

Acumen Research and Consulting is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

For Latest Update Follow Us on Twitter and, LinkedIn

SIGA Technologies, maker of the only available monkeypox treatment, is working to ramp up manufacturing for broader global distribution.

We just can't get a break from COVID. While things were inching closer towards normalcy, cases are rising again thanks to the latest dominant variant BA.5, which experts say is the most contagious COVID strain yet. Although the virus affects everyone differently, there are symptoms to watch out for that indicate you've had COVID and Eat This, Not That! Health spoke with Dr. Mark Fischer, Regional Medical Director at International SOS who explains what to know about BA.5 and symptoms to watch out

AstraZeneca Plc (NASDAQ: AZN) has removed a Moderna Inc (NASDAQ: MRNA)-partnered cardiovascular disease candidate from its phase 2 pipeline. The Moderna-partnered candidate is AZD8601, a therapy based on mRNA encoding vascular endothelial growth factor (VEGF-A). In EPICCURE Phase 2a trial, the investigators injected the mRNA directly into the myocardium of patients undergoing elective coronary artery bypass surgery. Related: AstraZeneca Q2 Highlights: Profits Fall, COVID-19 Vaccine Sales Dip, Li

The company had said it was in talks with the FDA about seeking early approval, but Wall Street analysts thought the agency would make it wait to apply.

The Biden administration plans to offer updated Covid booster shots in September, an administration official confirmed to NBC News on Friday.

The Biden administration said it would spend $1.74 billion to buy 66 million doses of Moderna updated Covid-19 vaccine, as well as the option to purchase up to 234 million additional doses, as part of a fall booster campaign. The deal Friday, which follows an agreement to buy 105 million doses of updated vaccines from Pfizer and partner BioNTech SE is expected to give the federal government enough shots for a booster push as early as September. Under the latest deal, the U.S. government has the option to buy up to an additional 234 million doses from Moderna.

AstraZeneca's Covid-19 antibody drug slashes the risk of new variants emerging, the company said, as Britain faces mounting pressure to follow other Western nations in ordering doses.

Is Pfizer stock a sell after Wall Street reduced its expectations for 2022 sales and profit? Is PFE stock a sell right now?

Joining me today is Brian Lian, Viking's president and CEO; and Greg Zante, Viking's CFO. Before we begin, I'd like to caution that comments made during this conference call today, July 27, 2022, will contain forward-looking statements under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements about Viking's expectations regarding its development activities, time lines and milestones.

Is Merck stock a buy as reports suggest it could put up $40 billion to acquire Seagen? Is MRK stock a buy right now?

San Francisco Mayor London Breed declares a state of emergency Thursday over monkeypox outbreak.

Dementia is a brain disorder that affects an estimated 55 million people worldwide according to the World Health Organization. The condition is becoming more common and while age is a leading risk factor, people under 65 can also have dementia, which causes memory loss, mood changes, getting lost in familiar places and more. Being aware of other risk factors like lack of sleep, poor diet, social isolation and not enough exercise can make a difference, but so does knowing your blood type, accordi

CHICAGO (Reuters) -People at high risk of severe disease who have yet to get a second COVID-19 booster should not wait for next-generation, Omicron-targeted vaccines expected in the fall, five vaccine experts told Reuters. In many countries, including the United States, the BA.5 Omicron subvariant of the virus is surging, but current vaccines continue to offer protection against hospitalization for severe disease and death. And, as the virus evolves, it is not known what version will be widely circulating in the fall or whether new vaccines - expected to target BA.4/5 in the United States and BA.1 in Europe - will be a good match.

The U.S. government has secured 66 million doses of Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccine booster candidate, mRNA-1273.222, a bivalent booster candidate containing Spikevax plus the omicron BA.4/5 strain mRNA. The contract includes an award of up to $1.74 billion for manufacturing and delivering 66 million doses of mRNA-1273.222 and options to purchase up to an additional 234 million doses of COVID-19 vaccine booster candidates. In June, Moderna released new data showing that one month a

July 26 marks the 32nd anniversary of the Americans with Disabilities Act (ADA) ― an important civil rights law that works to ensure all people with disabilities have the same rights and opportunit...

One third of Americans have high blood pressure, known as hypertension. "When your blood pressure is too high for too long, it puts you at risk for heart disease, stroke, kidney damage or an aneurysm formation," says Colin A. Craft, MD, physician at Penn Heart and Vascular Center Washington Square. Luckily there are some simple lifestyle changes that can help lower blood pressure. Read on—and to ensure your health and the health of others, don't miss these Sure Signs You've Already Had COVID. 1

If a decision is made to choose abortion, it is because what is lost to that woman and her family is balanced against what is gained.

Three weeks before the Supreme Court overturned Roe v. Wade, Dr. Caitlin Bernard, an Indianapolis obstetrician-gynecologist, donned her white lab coat, put her infant daughter into a front-pack baby carrier and joined a few colleagues who marched to the state Capitol, hoping to deliver a letter to Gov. Eric Holcomb. Signed by hundreds of health professionals, the letter implored Holcomb, a Republican, not to convene a special legislative session to further restrict abortions. It contained a poin

The chiropractor told her mother that she was ‘having a reaction to the treatment.’”

Story at a glance For the study, more than 501,000 people with an average age of 56 from a U.K database filled out questionnaires asking how often they participated in various physical activities, household and job-related tasks and mental activities, like social visits. Participants reported their family history for dementia to help researchers narrow down…